Industry News
Salt imbalance occurs in nearly a third of hospitalised patients
Feb 25, 2014
Simple guidelines for diagnosing and treating a salt imbalance occurring in up to 30% of hospitalised patients are published in the European Journal of Endocrinology. The guidelines recommend that any hospital-based clinician must be able to correctly diagnose, classify and treat hyponatraemia, which is associated with morbidity, mortality and length of hospital stay in a wide range of conditions. Read More
Experimental treatment eradicates acute leukemia in mice
Feb 25, 2014
A diverse team of scientists from UCLA's Jonsson Comprehensive Cancer Center have developed an experimental treatment that eradicates an acute type of leukemia in mice without any detectable toxic side effects. The drug works by blocking two important metabolic pathways that the leukemia cells need to grow and spread.The study, led by Dr. Read More
Cancer patients want more written information on late effects
Feb 25, 2014
Patients who undergo radiotherapy for pelvic cancers want to be better informed about side effects before treatment, research has revealed.Half of patients who took part in a UK survey reported unmet information needs on a range of issues, including rehabilitation, ways to access supportive services and how to cope with the treatment's sexual consequences. Read More
Experimental treatment eradicates acute leukemia in mice
Feb 25, 2014
A diverse team of scientists from UCLA's Jonsson Comprehensive Cancer Center have developed an experimental treatment that eradicates an acute type of leukemia in mice without any detectable toxic side effects. The drug works by blocking two important metabolic pathways that the leukemia cells need to grow and spread.The study, led by Dr. Read More
Enzalutamide for metastatic prostate cancer: IQWiG assessed data subsequently submitted by the manufacturer
Feb 25, 2014
Now indication and hint of major added benefit for patients with metastatic prostate cancerEnzalutamide (trade name: Xtandi) has been approved since June 2013 for men with metastatic prostate cancer in whom the commonly used hormone blockade is no longer effective and who have already been treated with the cytostatic drug docetaxel. Read More
Study offers hope for patients with advanced cervical cancer
Feb 25, 2014
Research on cervical cancer performed by a physician at the University of Arizona Cancer Center at St. Joseph's Hospital and Medical Center has been published in the New England Journal of Medicine. The multi-site research project by Bradley J. Monk, MD, is expected to change the standard of care for women with advanced cervical cancer. Read More
Enzalutamide for metastatic prostate cancer: IQWiG assessed data subsequently submitted by the manufacturer
Feb 25, 2014
Now indication and hint of major added benefit for patients with metastatic prostate cancerEnzalutamide (trade name: Xtandi) has been approved since June 2013 for men with metastatic prostate cancer in whom the commonly used hormone blockade is no longer effective and who have already been treated with the cytostatic drug docetaxel. Read More
Study offers hope for patients with advanced cervical cancer
Feb 25, 2014
Research on cervical cancer performed by a physician at the University of Arizona Cancer Center at St. Joseph's Hospital and Medical Center has been published in the New England Journal of Medicine. The multi-site research project by Bradley J. Monk, MD, is expected to change the standard of care for women with advanced cervical cancer. Read More
Increased risk of prostate cancer in some men taking selenium and vitamin E supplements
Feb 25, 2014
A multi-center study led by Fred Hutchinson Cancer Research Center has found that high-dose supplementation with both the trace element selenium and vitamin E increase the risk of high-grade prostate cancer. But importantly, this risk depends upon a man's selenium status before taking the supplements. Read More
Researchers enhance anti-cancer benefits, increase shelf life of broccoli
Feb 25, 2014
While researching methods to increase the already well-recognized anti-cancer properties of broccoli, researchers at the University of Illinois also found a way to prolong the vegetable's shelf life. Read More
Previous Page Next Page